Skip to Main Content

Columbia

  • sam patrick posted an article
    Top speakers and brands are committing to attend SCBIO 2017 in Charleston this October; have you sig see more

    BIO global CEO Jim Greenwood will join South Carolina Governor Henry McMaster as featured luncheon speakers on the first full day of SCBIO 2017 – the annual conference bringing top leaders and executives from organizations across the life sciences industry to Charleston, South Carolina October 24–26.

    Mr. Greenwood will be addressing the gathering with a keynote presentation entitled “Global Trends for the Life Sciences Industry – and Implications for South Carolina” at lunch on October 25.  South Carolina Governor Henry McMaster will follow with a presentation entitled “Life Sciences Powered by Public/Private Partnership – A Strategic View from the Statehouse.”

    Dozens of top industry chief executives, leaders in government and higher education, biotechnology and pharma executives, and industry supporters from across America have already committed to attend SCBIO 2017 at Charleston’s Gaillard Auditorium, organizers confirmed today.  Among the committed speakers and panelists are Nephron Pharmaceuticals CEO Lou Kennedy, MUSC President David Cole, Clemson University President Jim Clements, USC President Harris Pastides, Medpoint CEO Chuck Crumpton, Belimed CEO Joseph McDonald, AVX Health Division executive Robert Fairey and numerous others.

    Themed “Building the Business of Life SCiences in SC”, the 2+ day conference draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion.  Committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, pharmaceuticals, diagnostics and testing, digital health and health IT, bio ag  and more.  While space is limited and advance registration is required, interested attendees can still register at http://scbio2017.eventbrite.com.

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has an $11.4 billion economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products. 

    SCBIO 2017 kicks off Tuesday evening with a Welcome Reception for conference registrants, speakers and sponsors on the rooftop terrace of the Grand Bohemian Hotel.  Wednesday will feature a full day of sessions beginning at breakfast with a greeting by Charleston Mayor John Tecklenburg and continuing through an evening reception.  The conference will wrap up Thursday at lunchtime. 

    “The life sciences industry has become a major driver of South Carolina’s economy,” noted South Carolina Secretary of Commerce Bobby Hitt recently. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, we know that this sector has tremendous growth potential, and we’re excited to be partnering with SCBIO to help life sciences continue to advance in South Carolina.”  SC Commerce is a Founding Partner of SCBIO and of the Conference.

    Among the leading biotech industry brands participating in the conference are Nephron Pharmaceutical, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Ritedose Corporation, Rhythmlink, Softbox, NCGS and SEMDA.  All of South Carolina’s research universities – MUSC, Clemson and the University of South Carolina – are attending, as is Greenville Health System and economic development entities including SCRA, the Upstate SC Alliance, the Charleston Regional Development Alliance and SiMT.

    As the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations – SCBIO members include hundreds of academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.

    For additional information on SCBIO, visit www.SCBIO.org.  To register for SCBIO 2017, visit http://scbio2017.eventbrite.com

  • Ty Kourlas posted an article
    S.C. life science group, SCBIO, names new leader as young industry gains attention. see more

    A longtime booster of the Upstate's economy is taking on a new challenge with a broader reach and a narrower focus: growing South Carolina's nascent life sciences industry.

    SCBIO - a trade group representing biotechnology companies - has named Sam Konduros its next president and CEO, a move that comes as state officials increasingly eye the business as a target for South Carolina's economy.

    Konduros, a former SCBIO board member, comes to the group from the Greenville Health System, where he ran an office that helped doctors take their inventions to market. Previously, he was the first president of the Upstate SC Alliance, the region's economic-development agency.

     

    At Greenville-based SCBIO - short for the S.C. Biotechnology Industry Organization - he'll be tasked with helping to grow an industry that's only recently taken shape here.

    The life sciences cover a broad mix of companies, from firms developing new drugs and researchers inventing medical devices to the manufacturers that make them. And while the state has a toehold into most corners of the sector, it's still relatively small here, employing about 17,500 workers statewide.

    "It's a young industry that has the opportunity to grow into a powerful economic bookend for South Carolina," Konduros said.

    The group's outgoing president, Wayne Roper, is credited with helping to map out its extent. His last task in the role is to finish a study backed by the S.C. Commerce Department outlining what life science companies are in the state, and where it's best poised to grow.

    When he starts next month, Konduros's job will be to take those findings and bring them to fruition. The issues facing the life sciences industry, meantime, aren't so different from the state's technology sector as a whole.

    New companies face challenges finding investments to fund their early operations before revenue rolls in. And the state is often overlooked amid regional powerhouses like Atlanta and North Carolina's Research Triangle.

    Konduros says he'd like to turn that tide by marketing South Carolina to investors and industry executives - to sell them on the state's research universities and its emerging startup community. And he expects to take that message to the state's General Assembly, too.

    Meantime, economic-development agencies have warmed to the sector recently. At the Commerce Department, the state Council on Competitiveness is now targeting biotech as a growth area for the state. And in the Lowcountry, the Charleston Regional Development Alliance is studying the sector as well.

    "We're at a critical time for that growth," said Erin Ford, SCBIO's board chair. "When you have change it's an opportunity to really listen and take stock."

     

    Read more at...

    http://www.postandcourier.com/business/s-c-life-science-group-names-new-leader-as-young/article_4eda6e1c-09c3-11e7-8626-9fe278c1fa12.html

  • Ty Kourlas posted an article
    SCBIO named Sam Konduros, as the new president and CEO of the statewide not-for-profit entity see more

    The South Carolina Biotechnology Industry Organization (SCBIO) named Sam Konduros, a business leader and biomedical and economic development consultant, as the new president and CEO of the statewide not-for-profit entity. SCBIO represents and catalyzes innovators in medicine, medical devices and biomaterials.

    Konduros, a member of the SCBIO board, is the founder of SK Strategies LLC launched in 2004, and has led or consulted numerous state economic development efforts. He also served as executive director of Greenville Health System’s Research Development Corporation from 2014 to 2016.

    “Sam’s strengths in knowing the biotech sector and his deep experience in business and economic development were compelling,” said Erin Ford, Chair of SCBIO.  “The board was won over by his vision for the growth of SCBIO.”

     

    As executive director for the GHS RDC, Konduros worked to facilitate tech transfer, attract new biomedical companies and grow collaborations between clinicians, researchers, and health educators while nurturing startups in shared lab space. He also chaired the healthcare system’s IP Committee, and helped develop the concept for a new life sciences innovation district referred to as the IMED Innovation Corridor.

    “I greatly appreciate the SCBIO board’s passion for serving and advancing South Carolina’s rapidly growing life sciences community and industry sector, and for their vote of confidence in my leadership capabilities for the organization going forward,“ Konduros said. “I am highly motivated to get officially started in this exciting new role in late April, and I am confident we will have some dynamic and innovative new initiatives to announce by the time our annual conference takes place in Charleston Oct. 25-26.”

    Konduros also served as a multi-year consultant to help forge the Clemson University’s International Center for Automotive Research (CU-ICAR).  He was the founding president and CEO of The Upstate SC Alliance. Konduros is a former Cancer Society chairman, Greenville Chamber chairman, and SC Chamber of Commerce executive committee member. He has a law degree from the University of South Carolina and undergraduate degree from Clemson.

    Read more at....

    https://upstatebusinessjournal.com/news/konduros-new-scbio-president-ceo/